3 COVID Stocks That Might Double Soon

3 COVID Stocks That Might Double Soon

3 COVID Stocks That Might Double Soon

Motley Fool author, Patrick Bafuma, thinks InMode (NASDAQ: INMD) will close out 2021 with a bang. As the world slowly returns to normal and consumers seek treatments that they had delayed due to COVID-19, the aesthetics market is sure to heat up and is expected to grow, so there is plenty of room to run for InMode. “InMode (sic) demand is strong. Over one-third of the new patients coming in have never had any aesthetics procedure done before, “says InMode chief medical officer Dr. Spero Theodorou, “Waiting lists are about a month out.” With many of us either in the house or masked up since March 2020, Bafuma expects continued growth for InMode.

Read the article here.

How can we help?

Please select a topic below related to your inquiry.

Find a clinic
Questions about treatments
Questions about our technologies or workstations
General inquiries email or call 1.855.411.2639

GET STARTED

Which technology is right for you?

Contact Us
Contact Us

Contact Us